Newsfeeds Archive - Page 456 of 461

1 minute read

Avidity Biosciences Or Dyne Therapeutics – Read On Raymond James’ Rating Skew

July 12, 2:54 PM

Raymond James initiated coverage on Avidity Biosciences Inc (NASDAQ:RNA) with a Strong Buy rating and $29 price target (68% upside) and Dyne Therapeutics Inc (NASDAQ:DYN)…

DYN

1 minute read

HC Wainwright Sees Agile Therapeutics’ Twirla Tailwinds Post Roe-Wade Ruling

By Vandana Singh

July 12, 2:33 PM

Agile Therapeutics Inc's (NASDAQ: AGRX) Twirla, the only low-dose transdermal hormonal contraceptive, should have tailwinds protected after the Supreme Court overturned Roe vs. Wade ruling that legalized abortion nationwide.

AGRX

1 minute read

Hoth Therapeutics Shares Surge On Encouraging Preclinical Data From Alzheimer’s Program

By Vandana Singh

July 12, 2:24 PM

Hoth Therapeutics Inc (NASDAQ:HOTH) has announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimer’s disease mouse model. HT-ALZ…

HOTH

1 minute read

Analysts Cuts Price Target On MacroGenics – Read Why

By Vandana Singh

July 12, 1:56 PM

BMO Capital Markets downgraded MacroGenics Inc (NASDAQ:MGNX) to Market Perform following the discontinuation of enoblituzumab (B7H3 antibody) for head and neck cancers. The…

MGNX

1 minute read

Despite Durability Questions, BMO Upgraded This Natural-Killer Cell Therapy Oncology Stock

By Vandana Singh

July 12, 1:44 PM

BMO Capital Market upgraded Fate Therapeutics Inc (NASDAQ:FATE) to Outperform from Market Perform. The analyst believes Fate’s iPSC platform is uniquely positioned…

FATE

1 minute read

Abbott’s Deep Brain Stimulation Receives FDA’s Breakthrough Device Tag To Manage Depression

By Vandana Singh

July 12, 10:20 AM

The FDA has granted Breakthrough Device Designation to Abbott Laboratories (NYSE:ABT) deep brain stimulation (DBS) system in treatment-resistant depression (TRD), a form…

ABT

1 minute read

Novo Integrated Shares Jump On Upbeat Q3 Interim Sales

By Vandana Singh

July 12, 5:53 AM

Novo Integrated Sciences Inc (NASDAQ:NVOS) sees Q3 FY22 sales of $13.4 million – $13.9 million, an increase of approximately 367%…

NVOS

1 minute read

Iterum Therapeutics Shares Are Surging – Read Why

By Vandana Singh

July 11, 2:31 PM

Iterum Therapeutics plc (NASDAQ:ITRM) has agreed with the FDA under the special protocol assessment (SPA) process on the design, endpoints, and…

ITRM

1 minute read

Needham Previews Neurocrine’s Upcoming Mid-Stage Data from Essential Tremor Study

By Vandana Singh

July 11, 2:20 PM

Needham previews the upcoming Phase 2 data readout for Neurocrine Biosciences Inc's (NASDAQ: NBIX) NBI-827104, a t-type calcium channel blocker in essential tremor (ET), by mid-2022.

JAZZ

1 minute read

Why NuCana Shares Are Rising Today?

By Vandana Singh

July 11, 1:36 PM

Regional Court of Dusseldorf has ruled in favor of NuCana plc (NASDAQ:NCNA), stating that Gilead Sciences Ireland UC and Gilead Sciences GmbH…

GILD